170 related articles for article (PubMed ID: 25057862)
21. Updates from the Neuro-Oncology Section of the 2015 American Neurological Association Annual Meeting.
Lukas RV; Wainwright DA; Laterra JJ
Future Oncol; 2016 Jan; 12(2):143-7. PubMed ID: 26616737
[TBL] [Abstract][Full Text] [Related]
22. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
23. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Herbst RS; Bajorin DF; Bleiberg H; Blum D; Hao D; Johnson BE; Ozols RF; Demetri GD; Ganz PA; Kris MG; Levin B; Markman M; Raghavan D; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Vokes EE; Winn RJ; Mayer RJ;
J Clin Oncol; 2006 Jan; 24(1):190-205. PubMed ID: 16326753
[TBL] [Abstract][Full Text] [Related]
24. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.
Sheikh AR; Hsu T; Subbiah IM; Arora SP
J Geriatr Oncol; 2019 Nov; 10(6):998-1002. PubMed ID: 31326394
[No Abstract] [Full Text] [Related]
25. [ASCO-update 2015 - highlights of the 51. meeting of the american society of clinical oncology/ASCO 2015].
Lorenzen S; Arnold D; Fottner C; Leichsenring J; Moehler M; Seufferlein T; Vogel A; Weber MM; Reinacher-Schick A
Z Gastroenterol; 2016 Feb; 54(2):167-72. PubMed ID: 26854837
[TBL] [Abstract][Full Text] [Related]
26. Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Rahman R; Polley MC; Alder L; Brastianos PK; Anders CK; Tawbi HA; Mehta M; Wen PY; Geyer S; de Groot J; Zadeh G; Piantadosi S; Galanis E; Khasraw M
Lancet Oncol; 2023 Apr; 24(4):e161-e171. PubMed ID: 36990614
[TBL] [Abstract][Full Text] [Related]
27. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Li J; Ng J; Allendorf J; Saif MW
JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
[TBL] [Abstract][Full Text] [Related]
28. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
29. The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005.
Montemurro F; Valabrega G; Garetto L; Aliberti S; Grignani G; Ortega C; Leone F; Ponzone R; Aglietta M
Expert Opin Pharmacother; 2005 Dec; 6(16):2907-21. PubMed ID: 16318441
[TBL] [Abstract][Full Text] [Related]
30. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
[TBL] [Abstract][Full Text] [Related]
31. Highlights from the 2022 Annual ASCO Meeting: Hematology/oncology expert Sonali Smith, MD shares her choices of interesting results from studies presented at this year's meeting Chicago: Hematology/oncology expert Sonali Smith, MD shares her choices of interesting results from studies presented at this year's meeting Chicago.
O'Rourke K
Cancer; 2022 Aug; 128(16):3010-3011. PubMed ID: 35860919
[No Abstract] [Full Text] [Related]
32. Disparities in Neuro-Oncology.
Michaelson NM; Watsula A; Bakare-Okpala A; Mohamadpour M; Chukwueke UN; Budhu JA
Curr Neurol Neurosci Rep; 2023 Dec; 23(12):815-825. PubMed ID: 37889427
[TBL] [Abstract][Full Text] [Related]
33. Diabetes and pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Hsu C; Saif MW
JOP; 2011 Jul; 12(4):330-3. PubMed ID: 21737889
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
35. American Society of Clinical Oncology 2021 Annual Meeting updates on primary brain tumors and CNS metastatic tumors.
Baskaran AB; Kumthekar P; Heimberger AB; Lukas RV
Future Oncol; 2021 Nov; 17(33):4425-4429. PubMed ID: 34672682
[TBL] [Abstract][Full Text] [Related]
36. [ASCO update -- highlights of the 40th Meeting of the American Society of Clinical Oncology/ASCO 2004].
Graeven U; Heike M; Höhler T; Lutz MP; Messmann H; Seufferlein T; Eberl T
Z Gastroenterol; 2004 Dec; 42(12):1416-24. PubMed ID: 15592968
[No Abstract] [Full Text] [Related]
37. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
[TBL] [Abstract][Full Text] [Related]
38. Trial results presented at ASCO's annual meeting highlight therapy de-escalation strategies: This year's American Society of Clinical Oncology annual meeting focused on the impact that targeted therapies can have on progression-free and disease-free survival.
Nierengarten MB
Cancer; 2023 Aug; 129(16):2438-2439. PubMed ID: 37475536
[No Abstract] [Full Text] [Related]
39. American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors section.
Wen PY
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1367-9. PubMed ID: 20836670
[TBL] [Abstract][Full Text] [Related]
40. Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Makrilia N; Syrigos KN; Saif MW
JOP; 2011 Jul; 12(4):351-4. PubMed ID: 21737894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
